FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 24, 2018--
MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Women’s
Radiology Associates, LLP, a private radiology physician group based in
Houston. The practice will integrate with Synergy Radiology Associates,
a MEDNAX-affiliated physician practice, also based in Houston.
This marks the Company’s sixth radiology services practice acquisition,
further establishing MEDNAX as the partner of choice for leading
radiology practices and physician services by combining physician
excellence with world-class technological capabilities.
Women’s Radiology Associates was established in 1974 by physicians who
pioneered fetal growth assessment research, a groundbreaking approach to
assess in-utero fetal growth. Comprising six board-certified
radiologists, the group provides a broad range of inpatient and
outpatient diagnostic imaging services at The Woman’s Hospital of Texas.
Specialized services include mammography, obstetric sonography,
gynecological sonography, computed tomography and neonatal imaging.
“Our highly experienced radiologists are recognized experts in women's
imaging, and we are proud to have served the community for the past 40
years as the only local radiology group exclusively performing women's
and neonatal imaging at The Woman’s Hospital of Texas,” said Yogesh P.
Shah, M.D., Managing Partner of Women’s Radiology Associates and
Chairman of the Department of Radiology at The Woman’s Hospital of
Texas. “We look forward to sharing this expertise with the greater
MEDNAX Radiology group while continuing to provide the high quality,
specialized patient care we are known for.”
“Women’s Radiology Associates is a welcome addition to MEDNAX Radiology
as we continue to expand our radiology physician services and enhance
our integrated physician services offering,” said Walid K. Adham, M.D.,
Practice Chair of Synergy Radiology Associates. “The team will add a
wealth of specialized expertise in women’s and neonatal imaging, and
Synergy is eager to continue to build upon the tradition of outstanding
clinical care provided by Dr. Shah and team at The Woman’s Hospital of
Upon completion of the transaction, MEDNAX’s affiliated radiologists
will read more than 11 million studies annually.
This was a cash transaction and it is expected to be immediately
accretive to earnings. No additional terms of the transaction were
With this acquisition, five physician group practices have become part
of MEDNAX in 2018.
MEDNAX, Inc. is a national health solutions partner based in Sunrise,
Fla. comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was
founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of
approximately 4,100 physicians in all 50 states and Puerto Rico. In
addition to its national physician network, MEDNAX provides services to
healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a revenue cycle management
company and a consulting services company. Additional information is
available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
View source version on businesswire.com: https://www.businesswire.com/news/home/20180424005335/en/
Source: MEDNAX, Inc.
Charles Lynch, 954-384-0175 Ext. 5692
President, Strategy and Investor Relations